| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |